A small molecule inhibitor, Nutilin-3, mediates p53 activation and sensitizes NSCLC cells to radiation therapy, leading to ionizing radiation (IR)-mediated premature senescence[9]. Here, TP53 is linked to non-small cell lung carcinoma.